These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6092974)

  • 1. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.
    Ferry DR; Goll A; Gadow C; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J; Goll A; Moosburger K; Glossmann H
    FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
    J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
    Nakayama K; Nozawa Y; Fukuta Y
    J Cardiovasc Pharmacol; 1994 May; 23(5):731-40. PubMed ID: 7521455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
    Goll A; Glossmann H; Mannhold R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):303-12. PubMed ID: 3027587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
    Goll A; Ferry DR; Glossmann H
    FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.
    Ptasienski J; McMahon KK; Hosey MM
    Biochem Biophys Res Commun; 1985 Jun; 129(3):910-7. PubMed ID: 2409972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
    Glossmann H; Ferry DR
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
    Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.
    Striessnig J; Zernig G; Glossmann H
    Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
    Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.